NCT05152433 (E-BRAiN) is a NA clinical trial of E-BRAiN therapy in Stroke, sponsored by University Medicine Greifswald.

Who is sponsoring NCT05152433?

NCT05152433 is sponsored by University Medicine Greifswald.

What drugs are being tested in NCT05152433?

Interventions in NCT05152433: E-BRAiN therapy, Conventional therapy.

What condition does NCT05152433 study?

NCT05152433 studies Stroke, Paresis, Neglect, Hemispatial.

Is NCT05152433 still recruiting?

NCT05152433 is currently status unknown. Last updated 8 December 2023.

Last reviewed 2023-12-08 · How we verify

NCT05152433: E-BRAiN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evidence-Based Robot-Assistant in Neurorehabilitation

Status unknown NA Last updated 8 December 2023

What this trial tests

NA trial testing E-BRAiN therapy in Stroke in 40 participants. Status unknown.

Timeline

4 October 2021

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	University Medicine Greifswald
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	4 October 2021
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	2 locations across Germany

Drugs / interventions tested

E-BRAiN therapy
Conventional therapy — full drug profile →

Conditions studied

Stroke — all drugs for Stroke →
Paresis — all drugs for Paresis →
Neglect, Hemispatial — all drugs for Neglect, Hemispatial →

Sponsor

University Medicine Greifswald

Who can join

18 and older, any sex, with Stroke or Paresis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the efficacy, acceptability, and safety of the therapeutic system E-BRAiN for the treatment of stroke-related impairments.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Reversing the Ruin: Rehabilitation, Recovery, and Restoration After Stroke.
Stockbridge MD, Bunker LD, Hillis AE. · · 2022 · cited 6× · PMID 36181577 · DOI 10.1007/s11910-022-01231-5
Analysis of the therapeutic interaction provided by a humanoid robot serving stroke survivors as a therapeutic assistant for arm rehabilitation.
Platz T, Pedersen AL, Deutsch P, Umlauft AN, et al · · 2023 · cited 2× · PMID 36950283 · DOI 10.3389/frobt.2023.1103017
Feasibility, coverage, and inter-rater reliability of the assessment of therapeutic interaction by a humanoid robot providing arm rehabilitation to stroke survivors using the instrument THER-I-ACT.
Platz T, Pedersen AL, Bobe S. · · 2023 · cited 2× · PMID 36909363 · DOI 10.3389/frobt.2023.1091283
Technology Acceptance and Usability of a Therapy System with a Humanoid Robot Serving as Therapeutic Assistant for Post-Stroke Arm and Neurovisual Rehabilitation-An Evaluation Based on Stroke Survivors' Experience.
Platz T, Umlauft AN, Pedersen AL, Forbrig P. · · 2025 · PMID 40422119 · DOI 10.3390/biomimetics10050289

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other University Medicine Greifswald trials

Trials by the same sponsor.

NCT06796374 — A Comparison of Fisetin Kinetics in Young and Old Adults · NA · recruiting
NCT06970171 — Acceptance of Mandibular Advancement Devices · NA · not yet recruiting
NCT06939608 — Kinetics of Yohimbine in Humans to Explore Sex and CYP2D6 Genotype Interactions · NA · completed
NCT06273241 — Impact of Food Intake on Berberine Kinetics · NA · completed
NCT06249451 — Staphylococcus Aureus Bacteraemia (SAB)-Support-Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05152433 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Medicine Greifswald
Last refreshed: 8 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05152433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing